{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:47:37Z","timestamp":1778568457859,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1245\/s10434-023-13279-9","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T19:04:13Z","timestamp":1677783853000},"page":"4444-4454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases"],"prefix":"10.1245","volume":"30","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Schell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaniel","family":"Kefleyesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazim","family":"Benzerdjeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Passot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alhadeedi","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"P\u00e9ron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahan","family":"Kepenekian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"13279_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8\u201310.","journal-title":"J Clin Oncol"},{"key":"13279_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejca.2020.08.009","volume":"139","author":"R Moretto","year":"2020","unstructured":"Moretto R, Rossini D, Zucchelli G, et al. Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy\u2013a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest. Eur J Cancer. 2020;139:81\u20139.","journal-title":"Eur J Cancer"},{"key":"13279_CR3","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"EV Cutsem","year":"2016","unstructured":"Cutsem EV, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann oncol. 2016;27:1386\u2013422.","journal-title":"Ann oncol"},{"key":"13279_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000454687","volume":"33","author":"JW Holch","year":"2017","unstructured":"Holch JW, Demmer M, Lamersdorf C, et al. Pattern and dynamics of distant metastases in metastatic colorectal cancer. Visc Med. 2017;33:70\u20135.","journal-title":"Visc Med"},{"key":"13279_CR5","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17:1709\u201319.","journal-title":"Lancet Oncol"},{"key":"13279_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Quenet","year":"2021","unstructured":"Quenet F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:256\u201366.","journal-title":"Lancet Oncol"},{"key":"13279_CR7","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/SLA.0b013e31827e9289","volume":"257","author":"D Goere","year":"2013","unstructured":"Goere D, Malka D, Tzanis D, et al. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg. 2013;257:1065\u201371.","journal-title":"Ann Surg"},{"key":"13279_CR8","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","volume":"89","author":"DG Jayne","year":"2002","unstructured":"Jayne DG, Fook S, Loi C, et al. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89:1545\u201350.","journal-title":"Br J Surg"},{"key":"13279_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejso.2020.07.038","volume":"47","author":"RL Dico","year":"2021","unstructured":"Dico RL, Faron M, Yonemura Y, et al. Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol. 2021;47:89\u2013100.","journal-title":"Eur J Surg Oncol"},{"key":"13279_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00423-019-01787-w","volume":"404","author":"A Pinto","year":"2019","unstructured":"Pinto A, Hobeika C, Philis A, et al. Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment? Langenbecks Arch Surg. 2019;404:477\u201388.","journal-title":"Langenbecks Arch Surg"},{"key":"13279_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ctrv.2012.11.003","volume":"39","author":"EMV de Cuba","year":"2013","unstructured":"de Cuba EMV, Kwakman R, Knol DL, et al. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies. Cancer Treat Rev. 2013;39:321\u20137.","journal-title":"Cancer Treat Rev"},{"key":"13279_CR12","doi-asserted-by":"crossref","unstructured":"Cremolini C, Antoniotti C, Stein A, et al. Individual patient data meta-analysis of FOLFOXIRI plus bevacizumab versus doublets plus bevacizumab as initial therapy of unresectable metastatic colorectal cancer. J Clin Oncol. 2020;38:JCO2001225.","DOI":"10.1200\/JCO.20.01225"},{"key":"13279_CR13","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1200\/JCO.22.00839","volume":"40","author":"D Rossini","year":"2022","unstructured":"Rossini D, Antoniotti C, Lonardi S, et al. Upfront modified fluorouracil, leucovorin, oxaliplatin, and irinotecan plus panitumumab versus fluorouracil, leucovorin, and oxaliplatin plus panitumumab for patients with RAS\/BRAF wild-type metastatic colorectal cancer: the phase III TRIPLETE study by GONO. J Clin Oncol. 2022;40:2878\u201388.","journal-title":"J Clin Oncol"},{"key":"13279_CR14","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.3390\/jcm10102131","volume":"10","author":"M Molla","year":"2021","unstructured":"Molla M, Fernandez-Plana J, Albiol S, et al. Limited liver or lung colorectal cancer metastases. Systemic treatment, surgery, ablation or SBRT. J Clin Med. 2021;10:2131.","journal-title":"J Clin Med"},{"key":"13279_CR15","unstructured":"Kepenekian V, Bhatt A, P\u00e9ron J, et al. Advances in the management of peritoneal malignancies. Nat Rev Clin Oncol. 2022;1\u201321."},{"key":"13279_CR16","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ejso.2020.07.041","volume":"46","author":"M H\u00fcbner","year":"2020","unstructured":"H\u00fcbner M, Kusamura S, Villeneuve L, et al. Guidelines for perioperative care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS\u00ae) society recommendations\u2014part I: preoperative and intraoperative management. Eur J Surg Oncol. 2020;46:2292\u2013310. https:\/\/doi.org\/10.1016\/j.ejso.2020.07.041.","journal-title":"Eur J Surg Oncol"},{"key":"13279_CR17","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1016\/j.ejso.2020.08.006","volume":"46","author":"M H\u00fcbner","year":"2020","unstructured":"H\u00fcbner M, Kusamura S, Villeneuve L, et al. Guidelines for perioperative care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS\u00ae) society recommendations\u2014part II: postoperative management and special considerations. Eur J Surg Oncol. 2020;46:2311\u201323. https:\/\/doi.org\/10.1016\/j.ejso.2020.08.006.","journal-title":"Eur J Surg Oncol"},{"key":"13279_CR18","doi-asserted-by":"publisher","first-page":"145749692210833","DOI":"10.1177\/14574969221083394","volume":"111","author":"IE Boukili","year":"2022","unstructured":"Boukili IE, Flaris AN, Mercier F, et al. Prehabilitation before major abdominal surgery: evaluation of the impact of a perioperative clinical pathway, a pilot study. Scand J Surg. 2022;111:145749692210833.","journal-title":"Scand J Surg"},{"key":"13279_CR19","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1245\/s10434-015-5005-2","volume":"23","author":"K Mohkam","year":"2016","unstructured":"Mohkam K, Passot G, Cotte E, et al. Resectability of peritoneal carcinomatosis: learnings from a prospective cohort of 533 consecutive patients selected for cytoreductive surgery. Ann Surg Oncol. 2016;23:1261\u201370.","journal-title":"Ann Surg Oncol"},{"key":"13279_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"13279_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res"},{"key":"13279_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29\u201342.","journal-title":"Ann Surg"},{"key":"13279_CR23","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1080\/02656736.2019.1635717","volume":"36","author":"F Mercier","year":"2019","unstructured":"Mercier F, Mohamed F, Cazauran J-B, et al. An update of peritonectomy procedures used in cytoreductive surgery for peritoneal malignancy. Int J Hyperth. 2019;36:744\u201352.","journal-title":"Int J Hyperth"},{"key":"13279_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1245\/ASO.2003.01.018","volume":"10","author":"O Glehen","year":"2003","unstructured":"Glehen O, Osinsky D, Cotte E, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003;10:863\u20139.","journal-title":"Ann Surg Oncol"},{"key":"13279_CR25","first-page":"1","volume":"34","author":"M Alyami","year":"2017","unstructured":"Alyami M, Kim BJ, Villeneuve L, et al. Ninety-day post-operative morbidity and mortality using the National Cancer Institute\u2019s common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperthermia. 2017;34:1\u20136.","journal-title":"Int J Hyperthermia"},{"key":"13279_CR26","doi-asserted-by":"publisher","first-page":"9073","DOI":"10.1245\/s10434-021-10190-z","volume":"28","author":"C Bakkers","year":"2021","unstructured":"Bakkers C, Lurvink RJ, Rijken A, et al. Treatment strategies and prognosis of patients with synchronous or metachronous colorectal peritoneal metastases: a population-based study. Ann Surg Oncol. 2021;28:9073\u201383.","journal-title":"Ann Surg Oncol"},{"key":"13279_CR27","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358\u201363.","journal-title":"Cancer"},{"key":"13279_CR28","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.21037\/apm-20-919","volume":"10","author":"ETJ Chandy","year":"2021","unstructured":"Chandy ETJ, Saxby HJ, Pang JW, Sharma RA. The multidisciplinary management of oligometastases from colorectal cancer: a narrative review. Ann Palliat Med. 2021;10:5988\u20136001.","journal-title":"Ann Palliat Med"},{"key":"13279_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ygyno.2018.06.022","volume":"150","author":"K Deng","year":"2018","unstructured":"Deng K, Yang C, Tan Q, et al. Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients. Gynecol Oncol. 2018;150:460\u20135.","journal-title":"Gynecol Oncol"},{"key":"13279_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0090-4295(02)02163-5","volume":"61","author":"K-R Han","year":"2003","unstructured":"Han K-R, Pantuck AJ, Bui MHT, et al. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. Urology. 2003;61:314\u20139.","journal-title":"Urology"},{"key":"13279_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/17474124.2020.1760839","volume":"14","author":"K Chen","year":"2020","unstructured":"Chen K, Deng X, Yang Z, et al. Sites of distant metastases and the cancer-specific survival of metastatic Siewert type II esophagogastric junction adenocarcinoma: a population-based study. Expert Rev Gastroent. 2020;14:491\u20137.","journal-title":"Expert Rev Gastroent"},{"key":"13279_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ygyno.2009.12.010","volume":"117","author":"JJ Jobsen","year":"2010","unstructured":"Jobsen JJ, ten Cate LN, Lybeert MLM, et al. The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor. Gynecol Oncol. 2010;117:32\u20136.","journal-title":"Gynecol Oncol"},{"key":"13279_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ejso.2018.10.540","volume":"45","author":"LR van der Werf","year":"2019","unstructured":"van der Werf LR, Wassenaar E, de Niet A, et al. The impact of radiological retroperitoneal lymphadenopathy on survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases. Eur J Surg Oncol. 2019;45:376\u201382.","journal-title":"Eur J Surg Oncol"},{"key":"13279_CR34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.ejso.2015.03.229","volume":"41","author":"J Gagni\u00e8re","year":"2015","unstructured":"Gagni\u00e8re J, Dupr\u00e9 A, Chabaud S, et al. Retroperitoneal nodal metastases from colorectal cancer: Curable metastases with radical retroperitoneal lymphadenectomy in selected patients. Eur J Surg Oncol. 2015;41:731\u20137.","journal-title":"Eur J Surg Oncol"},{"key":"13279_CR35","doi-asserted-by":"publisher","first-page":"712","DOI":"10.4143\/crt.2017.100","volume":"50","author":"SU Bae","year":"2017","unstructured":"Bae SU, Hur H, Min BS, et al. Which patients with isolated para-aortic lymph node metastasis will truly benefit from extended lymph node dissection for colon cancer? Cancer Res Treat. 2017;50:712\u20139.","journal-title":"Cancer Res Treat"},{"key":"13279_CR36","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1245\/s10434-014-4173-9","volume":"22","author":"S Salah","year":"2015","unstructured":"Salah S, Ardissone F, Gonzalez M, et al. Pulmonary metastasectomy in colorectal cancer patients with previously resected liver metastasis: pooled analysis. Ann Surg Oncol. 2015;22:1844\u201350.","journal-title":"Ann Surg Oncol"},{"key":"13279_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/SLA.0b013e318255486a","volume":"256","author":"G Passot","year":"2012","unstructured":"Passot G, Vaudoyer D, Cotte E, et al. Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis. Ann Surg. 2012;256:125\u20139.","journal-title":"Ann Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-13279-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T13:04:27Z","timestamp":1686229467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-13279-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["13279"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-13279-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"assertion":[{"value":"10 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This manuscript is not based on a previous communication. Authors have no conflict of interest to declare in line with that manuscript, except Prof. Olivier Glehen who is a consultant for GAMIDA.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}